1) ライプニッツ (著), 清水富雄, 竹田篤司, 飯塚勝久 (訳) : モナドロジー・形而上学叙説より (中公クラシックス) : 中央公論新社, pp13-14. 2005.
2) 岩田健太郎 (著) : 99・9%が誤用の抗生物質 医者も知らないホントの話 (光文社新書) : 光文社, 2013.
3) Wagner JG. History of pharmacokinetics. Pharmacol Ther. 1981 ; 12 (3) : 537-62.
4) Csajka C, Verotta D. Pharmacokinetic-Pharmacodynamic Modelling : History and Perspectives. J Pharmacokinet Pharmacodyn. 2006 Jan 11 ; 33 (3) : 227-79.
5) 日本化学療法学会 抗菌化学療法認定医認定制度審議委員会編集 : 抗菌薬適正使用生涯教育テキスト (改訂版), pp74. 2013.
6) Pai MP et al. Pharmacokinetics and Pharmacodynamics of Antiinfective Agents. In. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 8th ed. 2014.
7) Cheng H-P, Siu LK, Chang F-Y. Extended-spectrum cephalosporin compared to cefazolin for treatment of Klebsiella pneumoniae-caused liver abscess. Antimicrob Agents Chemother. 2003 Jul ; 47 (7) : 2088-92.
8) Lee SS-J et al. Predictors of Septic Metastatic Infection and Mortality among Patients with Klebsiella pneumoniae Liver Abscess. Clin Infect Dis. 2008 Jan 9 ; 47 (5) : 642-50.
9) Eagle H, Musselman AD. The rate of bactericidal action of penicillin in vitro as a function of its concentration, and its paradoxically reduced activity at high concentrations against certain organisms. J Exp Med. 1948 Jul 1 ; 88(1) : 99-131.
10) Brook I. Inoculum Effect. Clin Infect Dis. 1989 Jan 5 ; 11 (3) : 361-8.